4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000788
Director sold 55,569 shares at an average $19.59 ($1,088,561)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-14 | Sale : show line 1 in the form | −29,983 | $19.64 | $588,866 | 2,143,017 | I |
| 2017-08-15 | Sale : show line 2 in the form | −25,586 | $19.53 | $499,695 | 2,117,431 | I |
| Open-market sales · 55,569 sh · avg $19.59 · $1,088,561 | ||||||
Loading xslF345X03/vonemster_fm4aug142017.xml…